) UPCI's laboratory Animal Facility is located in the Biomedical Science Tower and is an AAALAC-approved facility. It is managed by the Department of Laboratory Animal Resources, University of Pittsburgh, headed by Paul H. Bramson, D.V.M. The Facility, which opened in 1991, was developed in response to the needs of the UPCI and other investigators whose research requires virus-free animals for their research. Many of the studies of the UPCI investigators concern the immunologic responses to tumors and often require long-term maintenance of mice and rats, including nude mice, for tumor development and experimental manipulations. Therefore, it is essential that the animals have a stable environmental background, without interruption by periodic and unpredictable microbial infections. Veterinary medical support staff is provided in conjunction with the University's Laboratory Animal Resources. The overall veterinary staff includes five veterinarians, one board certified veterinary pathologist, five animal health technicians and a histopathology technician. Most histopathology and microbiology can be performed in-house. A stringent program for monitoring the health and potential exposure to infectious agents of the animals housed has been implemented. Sentinel animals are placed in each animal room and are sampled quarterly to assess background pathology and viral antibody profiles. In addition to the direct supervision of the facility by Dr. Bramson and the Facility supervisor, policies involving other issues are dealt with by the Laboratory Animal Facility Committee, chaired by Dr. Candace S. Johnson, Deputy Director for Basic Research, and comprised of all investigators who house animals in the facility. This committee has formulated the Policies Regulating Use of the BST Animal Facility, and meets as needed, to discuss problems or issues related to the facility. Policies have been written to cover the purchasing, sources and health monitoring of the laboratory animals.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA047904-12
Application #
6212126
Study Section
Subcommittee G - Education (NCI)
Project Start
1988-08-01
Project End
2004-07-30
Budget Start
Budget End
Support Year
12
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Chen, Dongshi; Ni, Hong-Min; Wang, Lei et al. (2018) PUMA induction mediates acetaminophen-induced necrosis and liver injury. Hepatology :
Tahata, Shawn; Singh, Shivendra V; Lin, Yan et al. (2018) Evaluation of Biodistribution of Sulforaphane after Administration of Oral Broccoli Sprout Extract in Melanoma Patients with Multiple Atypical Nevi. Cancer Prev Res (Phila) 11:429-438
Moravcikova, Erika; Meyer, E Michael; Corselli, Mirko et al. (2018) Proteomic Profiling of Native Unpassaged and Culture-Expanded Mesenchymal Stromal Cells (MSC). Cytometry A 93:894-904
Samuelsson, Laura B; Bovbjerg, Dana H; Roecklein, Kathryn A et al. (2018) Sleep and circadian disruption and incident breast cancer risk: An evidence-based and theoretical review. Neurosci Biobehav Rev 84:35-48
Shiffman, Saul; Mao, Jason M; Kurland, Brenda F et al. (2018) Do non-daily smokers compensate for reduced cigarette consumption when smoking very-low-nicotine-content cigarettes? Psychopharmacology (Berl) 235:3435-3441
Cao, Chunyu; Wu, Hao; Vasilatos, Shauna N et al. (2018) HDAC5-LSD1 axis regulates antineoplastic effect of natural HDAC inhibitor sulforaphane in human breast cancer cells. Int J Cancer 143:1388-1401
Yochum, Zachary A; Cades, Jessica; Wang, Hailun et al. (2018) Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer. Oncogene :
Beumer, Jan H; Inker, Lesley A; Levey, Andrew S (2018) Improving Carboplatin Dosing Based on EstimatedĀ GFR. Am J Kidney Dis 71:163-165
Tong, Jingshan; Zheng, Xingnan; Tan, Xiao et al. (2018) Mcl-1 Phosphorylation without Degradation Mediates Sensitivity to HDAC Inhibitors by Liberating BH3-Only Proteins. Cancer Res 78:4704-4715
Menk, Ashley V; Scharping, Nicole E; Rivadeneira, Dayana B et al. (2018) 4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses. J Exp Med 215:1091-1100

Showing the most recent 10 out of 1187 publications